Table of Contents:

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising geriatric population
4.2.2 Rising cardiovascular diseases
4.2.3 Research and development
4.3 Restraints
4.3.1 High cost
4.3.2 Regulatory affairs
4.4 Opportunity
4.4.1 Entering developing markets
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Price Analysis
5.3 Investment Opportunity Analysis
5.4 Value Chain Analysis
5.4.1 Supporting Activity
5.4.2 Inbound Logistics
5.4.3 Operations
5.4.4 Marketing and Sales
5.4.5 Outbound Logistics
5.4.6 Customer Services
6 Global Cardiopulmonary Exercise Testing Market, by Product
6.1 Introduction
6.2 Cardiopulmonary Exercise Testing (CPET) Systems
6.3 Single-Photon Emission Computed Tomography (SPECT)
6.4 Echocardiogram
6.5 Pulse Oximeters
6.6 Stress Blood Pressure Monitors
7 Global Cardiopulmonary Exercise Testing Market, by End-User
7.1 Introduction
7.2 Hospitals and Clinics
7.3 Diagnostic Centers
7.4 Ambulatory Centers
7.5 Others
8 Global Cardiopulmonary Exercise Testing Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 UK
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East and Africa
8.5.1 Middle East
8.5.2 Africa
9 Company Landscape
9.1 Company Share Analysis
10 Company Profiles
10.1 Cardinal Health
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offering
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategy
10.2 COSMED srl
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offering
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategy
10.3 GE Healthcare
10.3.1 Company Overview
10.3.2 Financial Overview (Healthcare Segment)
10.3.3 Products Offering
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategy
10.4 Halma plc.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offering
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategy
10.5 Hill-Rom Holdings, Inc.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offering
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategy
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offering
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategy
10.7 MGC Diagnostics Corporation
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products Offering
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategy
10.8 NIHON KOHDEN CORPORATION
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products Offering
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategy
10.9 Schiller AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offering
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategy
10.1 Masimo Corporation
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products Offering
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategy
10.11 Vyaire Medical, Inc.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products Offering
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.11.6 Key Strategy
11 Appendix
11.1 Discussion Blue Print
11.2 References